ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FRX Forest Road Acquisition Corp

12.00
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Forest Road Acquisition Corp NYSE:FRX NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 12.00 0 01:00:00

Furiex Pharmaceuticals (FURX) Shareholder Alert - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Furiex Phar...

28/04/2014 2:21pm

PR Newswire (US)


Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Forest Road Acquisition Charts.

WILMINGTON, Del., April 28, 2014 /PRNewswire/ -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Furiex Pharmaceuticals, Inc. ("Furiex" or the "Company") (NASDAQ: FURX) relating to the sale of the Company to Forest Laboratories, Inc. (NYSE: FRX) (the "Forest Labs"). On April 28, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Forest Labs will acquire Furiex in a merger valued at roughly $1.1 billion. Furiex shareholders could earn up to an additional $360 million pursuant to certain contingent value rights ("CVRs"). As a result of the merger, Furiex shareholders are only anticipated to receive $95 per share in cash for each share of Furiex.

Based on our investigation, the consideration that Furiex shareholders are expected to receive is significantly inadequate. Analysts at Yahoo! Finance have set a $140 per share price target for Furiex, which is approximately 47% more than what Furiex shareholders are expected to receive.

If you own shares of Furiex and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/furiex or contact Craig J. Springer, Esq. at cspringer@andrewsspringer.com, or call toll free at 1-800-423-6013. This notice may constitute attorney advertising.

Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud and breaches of fiduciary duty. Our Firm's practice model consists of retaining a small select group of high caliber attorneys who are committed to protecting shareholder rights and litigating cutting-edge issues affecting shareholder rights. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for our clients. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute.

CONTACT:
Craig Springer
1-302-504-4957
cspringer@andrewsspringer.com

 

SOURCE Andrews & Springer LLC

Copyright 2014 PR Newswire

1 Year Forest Road Acquisition Chart

1 Year Forest Road Acquisition Chart

1 Month Forest Road Acquisition Chart

1 Month Forest Road Acquisition Chart

Your Recent History

Delayed Upgrade Clock